Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin for treating schizophrenia
IRCT201304143930N21Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lovastatin in schizophrenia, schizotypal personality disorder (STPD) and delusional disorder, sponsored by Shiraz University of Medical Sciences. Started Jul 2012; status: completed.
02
Drugs
lovastatin
03
Conditions
schizophreniaschizotypal personality disorder (STPD)delusional disorder
Beyond the preview
Go deeper on IRCT201304143930N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201304143930N21.